FDA to streamline approvals for generic biological drugs in latest move targeting health costs
By Deidre McPhillips, CNN (CNN) — The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate approvals of cheaper alternatives to medications that treat a wide range of illnesses, leading to increased market competition and
Continue Reading